US 12410442
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
granted A61KA61K48/005A61K48/0075
Quick answer
US patent 12410442 (Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K48/005, A61K48/0075, A61P, A61P27/16